MedTrace Logo

Humanin's Value for Early Diagnosis and Short-term Prognosis in Patients With AKI After Heart Transplantation

NCT06125249 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2023-11-09

No results posted yet for this study

Summary

The goal of this observational study is to explore the value of Humanin for early diagnosis and short-term prognosis of AKI patients after heart transplantation. The main question it aims to answer are:whether Humanin can be a novel marker for predicting AKI after heart transplantation Researchers will compare the Humanin concentration in patients with AKI did not occur after heart transplantation to see if Humanin can be a novel marker for predicting AKI after heart transplantation

Conditions

Sponsors & Collaborators

  • Li zhilian

    lead OTHER

Principal Investigators

  • zhilian PP li, doctor · Guangdong Provincial People's Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2024-06-30
Completion
2024-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06125249 on ClinicalTrials.gov